Is Sinopharm a Central Enterprise?

Sinopharm Group is a central enterprise. Sinopharm Group, namely China Pharmaceutical Group Co., Ltd., is a state-owned holding enterprise directly managed by the central government. China Pharmaceutical Group Co., Ltd. was established on March 26th, 1987, headquartered in Haidian District, Beijing, and its legal representative is Liu Jingzhen.

2065438+0910.8, 165438, the State Council State-owned Assets Supervision and Administration Commission released the list of central enterprises, and China Pharmaceutical Group Co., Ltd. ranked 78th ... Shareholders of China Pharmaceutical Group Co., Ltd.: National Development and Investment Group Co., Ltd., State-owned Assets Supervision and Administration Commission of the State Council, China Guo Xin Holding Co., Ltd.

Business scope of China Pharmaceutical Group Co., Ltd.: entrusted management and asset reorganization of pharmaceutical enterprises; Investment and consulting services in pharmaceutical industry; Holding exhibitions and sales of medical devices; Provide consulting services related to the main business; Import and export of goods; Technology import and export; Acting for import and export, etc.

Characteristics of central enterprises

It is generally believed that central enterprises mainly have three characteristics:

First, the financial relationship of assets is listed separately in the Ministry of Finance.

Second, personnel relations are listed separately in Ministry of Human Resources and Social Security.

Third, the operation should be listed separately in the national plan (the State Council can write it directly).